These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7361335)

  • 41. Dose mapping: validation in 4D dosimetry with measurements and application in radiotherapy follow-up evaluation.
    Zhang GG; Huang TC; Forster KM; Lin KP; Stevens C; Harris E; Guerrero T
    Comput Methods Programs Biomed; 2008 Apr; 90(1):25-37. PubMed ID: 18178288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating the influence of setup uncertainties on treatment planning for focal liver tumors.
    Balter JM; Brock KK; Lam KL; Tatro D; Dawson LA; McShan DL; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):610-4. PubMed ID: 16095848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NSD and cell survival.
    Lokajícek M; Kozubek S; Prokes K
    Br J Radiol; 1979 Jul; 52(619):571-2. PubMed ID: 465942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of radiotherapy treatment planes in terms of iso-TDF curves (author's transl)].
    Malgieri F; Furnari M
    Radiol Med; 1978 Sep; 64(9):1039-45. PubMed ID: 749027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Time factors in human skin desquamations (author's transl)].
    Dutreix J; Wambersie A
    J Radiol Electrol Med Nucl; 1976 Nov; 57(11):813-6. PubMed ID: 1011186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mathematical determination of treatment schedules according NSD concepts in radiotherapy (author's transl)].
    Salti C; Peracchia G
    Ateneo Parmense Acta Biomed; 1975; 46(6):597-608. PubMed ID: 1222069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Verification of the dose delivered to the patient by means of TLD, SC, PID. What future?].
    Noël A
    Cancer Radiother; 2003 Nov; 7 Suppl 1():78s-84s. PubMed ID: 15124548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low-dose X-irradiation of adjuvant-induced arthritis in rats. Efficacy of different fractionation schedules.
    Liebmann A; Hindemith M; Jahns J; Madaj-Sterba P; Weisheit S; Kamprad F; Hildebrandt G
    Strahlenther Onkol; 2004 Mar; 180(3):165-72. PubMed ID: 14991205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of physical and numerical techniques of Alanine/EPR dosimetry in radiotherapy.
    Castro F; Ponte F; Pereira L
    Radiat Prot Dosimetry; 2006; 122(1-4):509-12. PubMed ID: 17166873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo dosimetry with MOSFETs: dosimetric characterization and first clinical results in intraoperative radiotherapy.
    Consorti R; Petrucci A; Fortunato F; Soriani A; Marzi S; Iaccarino G; Landoni V; Benassi M
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):952-60. PubMed ID: 16199324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The development of radiotherapy: physics, technology methods.
    Acta Oncol; 1996; 35 Suppl 6():24-30. PubMed ID: 9154081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Real-time in vivo dosimetry using micro-MOSFET detectors during intraoperative electron beam radiation therapy in early-stage breast cancer.
    Ciocca M; Piazzi V; Lazzari R; Vavassori A; Luini A; Veronesi P; Galimberti V; Intra M; Guido A; Tosi G; Veronesi U; Orecchia R
    Radiother Oncol; 2006 Feb; 78(2):213-6. PubMed ID: 16359743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
    Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
    Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Interactive determination of the parameters of mathematical models for planning radiotherapy of malignant tumors. I. Mathematical models for calculating dose tolerance, adequate doses and the likelihood of development of radiation complications in normal organs and tissues].
    Klepper LIa
    Med Tekh; 2000; (4):37-41. PubMed ID: 10984881
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The biologic relevance of daily dose variations in adaptive treatment planning.
    Bortfeld T; Paganetti H
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):899-906. PubMed ID: 16751072
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time-dose effects in the matching of adjacent radiotherapy fields.
    Tatcher M; Yudelev M
    Radiology; 1978 Jan; 126(1):253-4. PubMed ID: 619421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biological effects evaluated as a function of patient thickness, beam quality, SSD,and treatment schedule.
    Bhatnagar JP; Feldman MI; Spira J
    Cancer; 1975 Jun; 35(6):1606-15. PubMed ID: 807315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The NSD nomogram for radiotherapy.
    Kumasawa A; Iino Y
    Jpn J Exp Med; 1977 Jun; 47(3):217-20. PubMed ID: 916297
    [No Abstract]   [Full Text] [Related]  

  • 59. A nomogram for time-dose-fractionation factors.
    Deye JA
    Radiology; 1979 May; 131(2):536-7. PubMed ID: 441351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protocol variations and their influence on the final outcome: critical review of the split-course base of tongue study of the RTOG.
    Ortiz H; Marcial VA; Hanley JA; Ramírez C; Pacheco JC
    Int J Radiat Oncol Biol Phys; 1985 May; 11(5):885-92. PubMed ID: 3886608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.